Glucose-conjugated chitosan nanoparticles for targeted drug delivery and their specific interaction with tumor cells

Jing Li1, Fang-Kui Ma2, Qifeng Dang3, Xingguo Liang1, Xiguang Chen3
1College of Food Science and Engineering, Ocean University of China, Qingdao 266003, China
2Freshwater Fisheries Research Institute of Shandong Province, Jinan, 250013, China
3College of Marine Life Science, Ocean University of China, Qingdao, 266003, China

Tóm tắt

Từ khóa


Tài liệu tham khảo

Chen C, Yu C H, Cheng Y C, et al. Biodegradable nanoparticles of amphiphilic triblock copolymers based on poly(3-hydroxybutyrate) and poly(ethylene glycol) as drug carriers. Biomaterials, 2006, 27(27): 4804–4814

Haley B, Frenkel E. Nanoparticles for drug delivery in cancer treatment. Urologic Oncology, 2008, 26(1): 57–64

Malam Y, Loizidou M, Seifalian A M. Liposomes and nanoparticles: nanosized vehicles for drug delivery in cancer. Trends in Pharmacological Sciences, 2009, 30(11): 592–599

Byrne J D, Betancourt T, Brannon-Peppas L. Active targeting schemes for nanoparticle systems in cancer therapeutics. Advanced Drug Delivery Reviews, 2008, 60(15): 1615–1626

Sudimack J, Lee R J. Targeted drug delivery via the folate receptor. Advanced Drug Delivery Reviews, 2000, 41(2): 147–162

Hruz P W, Mueckler M M. Structural analysis of the GLUT1 facilitative glucose transporter. Molecular Membrane Biology, 2001, 18(3): 183–193

Olson A L, Pessin J E. Structure, function, and regulation of the mammalian facilitative glucose transporter gene family. Annual Review of Nutrition, 1996, 16(1): 235–256

Warburg O, Wind F, Negelein E. The metabolism of tumors in the body. The Journal of General Physiology, 1927, 8(6): 519–530

Cullinane C, Solomon B, Hicks R J. Imaging of molecular target modulation in oncology: challenges of early clinical trials. Clinical and Translational Imaging, 2014, 2(1): 5–12

Liu D Z, Sinchaikul S, Reddy P V G, et al. Synthesis of 2′-paclitaxel methyl 2-glucopyranosyl succinate for specific targeted delivery to cancer cells. Bioorganic & Medicinal Chemistry Letters, 2007, 17(3): 617–620

Airley R, Evans A, Mobasheri A, et al. Glucose transporter Glut-1 is detectable in peri-necrotic regions in many human tumor types but not normal tissues: Study using tissue microarrays. Annals of Anatomy, 2010, 192(3): 133–138

Jóźwiak P, Lipińska A. The role of glucose transporter 1 (GLUT1) in the diagnosis and therapy of tumors. Postępy Higieny i Medycyny Doświadczalnej, 2012, 66: 165–174 (in Polish)

Ravi Kumar M N V. A review of chitin and chitosan applications. Reactive and Functional Polymers, 2000, 46(1): 1–27

Li J, Kong M, Cheng X J, et al. A facile method for preparing biodegradable chitosan derivatives with low grafting degree of poly(lactic acid). International Journal of Biological Macromolecules, 2011, 49(5): 1016–1021

Yang K, Gao T, Bao Z, et al. Preparation and characterization of a novel thermosensitive nanoparticle for drug delivery in combined hyperthermia and chemotherapy. Journal of Materials Chemistry B, 2013, 1(46): 6442–6448

Li P, Wang Y, Zeng F, et al. Synthesis and characterization of folate conjugated chitosan and cellular uptake of its nanoparticles in HT-29 cells. Carbohydrate Research, 2011, 346(6): 801–806

Chen X G, Li J, Cheng X J, et al. Process for preparing compounds of chitosan saccharified with aminosugar. US Patent, 8 202 971 B2, 2012-06-19

Hansen M B, Nielsen S E, Berg K. Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill. Journal of Immunological Methods, 1989, 119(2): 203–210

Dong Y, Feng S S. Methoxy poly(ethylene glycol)-poly(lactide) (MPEG-PLA) nanoparticles for controlled delivery of anticancer drugs. Biomaterials, 2004, 25(14): 2843–2849

Wang H, Zhao P, Su W, et al. PLGA/polymeric liposome for targeted drug and gene co-delivery. Biomaterials, 2010, 31(33): 8741–8748

Li J, Kong M, Cheng X J, et al. Preparation of biocompatible chitosan grafted poly(lactic acid) nanoparticles. International Journal of Biological Macromolecules, 2012, 51(3): 221–227

Danhier F, Feron O, Préat V. To exploit the tumor microenvironment: Passive and active tumor targeting of nanocarriers for anticancer drug delivery. Journal of Controlled Release, 2010, 148(2): 135–146

Yoo J W, Doshi N, Mitragotri S. Adaptive micro and nanoparticles: Temporal control over carrier properties to facilitate drug delivery. Advanced Drug Delivery Reviews, 2011, 63(14–15): 1247–1256

Hashida M, Takemura S, Nishikawa M, et al. Targeted delivery of plasmid DNA complexed with galactosylated poly(L-lysine). Journal of Controlled Release, 1998, 53(1–3): 301–310

Peer D, Karp J M, Hong S, et al. Nanocarriers as an emerging platform for cancer therapy. Nature Nanotechnology, 2007, 2(12): 751–760

Choucair A, Soo P L, Eisenberg A. Active loading and tunable release of doxorubicin from block copolymer vesicles. Langmuir, 2005, 21(20): 9308–9313

Xun W, Wang H Y, Li Z Y, et al. Self-assembled micelles of novel graft amphiphilic copolymers for drug controlled release. Colloids and Surfaces B: Biointerfaces, 2011, 85(1): 86–91